Table 2 Cost related clinical outcomes and hospitalization costs comparisons between groups
Clinical outcomes | Patients with lung disease | Patients with lung cancer | ||||||
|---|---|---|---|---|---|---|---|---|
Overall, n = 376 | Open lobectomy, n = 188 | VATS lobectomy, n = 188 | P-value | Overall, n = 326 | Open lobectomy, n = 163 | VATS lobectomy, n = 163 | P-value | |
Blood transfusion, n (%) | 10 (2.66) | 6 (3.19) | 4 (2.13) | 0.75 | 10 (3.07) | 4 (2.45) | 6 (3.68) | 0.75 |
Lung infection, n (%) | 115 (30.59) | 75 (39.89) | 40 (21.28) | < 0.001 | 95 (29.14) | 64 (39.26) | 31 (19.02) | < 0.001 |
Post-operative LOS (days), mean ± SD | 10.14 ± 4.08 | 10.86 ± 4.69 | 9.42 ± 3.22 | < 0.01 | 10.19 ± 4.25 | 11.06 ± 4.91 | 9.32 ± 3.25 | < 0.001 |
Total hospitalization costs (RMB), mean ± SD | 83181.47 ± 15090.94 | 81964.92 ± 16748.11 | 84398.03 ± 13161.13 | 0.12 | 84139.26 ± 15170.14 | 82848.46 ± 16928.87 | 85430.05 ± 13105.24 | 0.13 |
Total non-surgery costs (RMB), mean ± SD | 43850.38 ± 9324.20 | 45752.36 ± 10346.42 | 41948.40 ± 7747.54 | < 0.001 | 44520.89 ± 9474.80 | 46633.03 ± 10538.43 | 42408.75 ± 7749.95 | < 0.001 |